Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Osman Dar is active.

Publication


Featured researches published by Osman Dar.


The Lancet | 2007

Improvement of tuberculosis case detection and reduction of discrepancies between men and women by simple sputum-submission instructions: a pragmatic randomised controlled trial

Mishal S Khan; Osman Dar; Charalambos Sismanidis; Karam Shah; Peter Godfrey-Faussett

BACKGROUND In several settings, women with suspected tuberculosis are less likely to test smear positive than are men. Submission of poor-quality sputum specimens by women might be one reason for the difference between the sexes. We did a pragmatic randomised controlled trial to assess the effect of sputum-submission instructions on female patients. METHODS 1494 women and 1561 men with suspected tuberculosis attending the Federal Tuberculosis Centre in Rawalpindi, Pakistan, were randomly assigned between May and July, 2005 either to receive sputum-submission guidance before specimen submission or to submit specimens without specific guidance, according to prevailing practice. Of enrolled patients, 133 (4%) declined to participate. The primary outcome measure was the proportion of instructed and non-instructed women testing smear positive. Intention-to-treat analysis was undertaken on the basis of treatment allocation. This study is registered with the International Standard Randomised Controlled Trial number 34123170. FINDINGS Instructed women were more likely to test smear positive than were controls (Risk ratio 1.63 [95% CI 1.19-2.22]). Instructions were associated with a higher rate of smear-positive case detection (58 [8%] in controls vs 95 [13%] in the intervention group; p=0.002), a decrease in spot-saliva submission (p=0.003), and an increase in the number of women returning with an early-morning specimen (p=0.02). In men, instructions did not have a significant effect on the proportion testing smear positive or specimen quality. INTERPRETATION In the Federal Tuberculosis Centre in Rawalpindi, lower smear positivity in women than in men was mainly a function of poor-quality specimen submission. Smear positivity in women was increased substantially by provision of brief instructions. Sputum-submission guidance might be a highly cost-effective intervention to improve smear-positive case detection and reduce the disparity between the sexes in tuberculosis control in low-income countries.


The Lancet | 2016

International cooperation to improve access to and sustain effectiveness of antimicrobials

Christine Årdal; Kevin Outterson; Steven J. Hoffman; Abdul Ghafur; Mike Sharland; Nisha Ranganathan; Richard Smith; Anna Zorzet; Jennifer Cohn; Didier Pittet; Nils Daulaire; Chantal M. Morel; Zain Rizvi; Manica Balasegaram; Osman Dar; David L. Heymann; Alison Holmes; Luke S. P. Moore; Ramanan Laxminarayan; Marc Mendelson; John-Arne Røttingen

Securing access to effective antimicrobials is one of the greatest challenges today. Until now, efforts to address this issue have been isolated and uncoordinated, with little focus on sustainable and international solutions. Global collective action is necessary to improve access to life-saving antimicrobials, conserving them, and ensuring continued innovation. Access, conservation, and innovation are beneficial when achieved independently, but much more effective and sustainable if implemented in concert within and across countries. WHO alone will not be able to drive these actions. It will require a multisector response (including the health, agriculture, and veterinary sectors), global coordination, and financing mechanisms with sufficient mandates, authority, resources, and power. Fortunately, securing access to effective antimicrobials has finally gained a place on the global political agenda, and we call on policy makers to develop, endorse, and finance new global institutional arrangements that can ensure robust implementation and bold collective action.


The Lancet | 2016

Exploring the evidence base for national and regional policy interventions to combat resistance

Osman Dar; Rumina Hasan; Jørgen Schlundt; Stéphan Juergen Harbarth; Grazia Caleo; Fazal K Dar; Jasper Littmann; Mark Rweyemamu; Emmeline J. Buckley; Mohammed Shahid; Richard Kock; Henry Lishi Li; Haydar Giha; Mishal S Khan; Anthony D. So; Khalid M. Bindayna; Anthony Kessel; Hanne Bak Pedersen; Govin Permanand; Alimuddin Zumla; John-Arne Røttingen; David L. Heymann

The effectiveness of existing policies to control antimicrobial resistance is not yet fully understood. A strengthened evidence base is needed to inform effective policy interventions across countries with different income levels and the human health and animal sectors. We examine three policy domains-responsible use, surveillance, and infection prevention and control-and consider which will be the most effective at national and regional levels. Many complexities exist in the implementation of such policies across sectors and in varying political and regulatory environments. Therefore, we make recommendations for policy action, calling for comprehensive policy assessments, using standardised frameworks, of cost-effectiveness and generalisability. Such assessments are especially important in low-income and middle-income countries, and in the animal and environmental sectors. We also advocate a One Health approach that will enable the development of sensitive policies, accommodating the needs of each sector involved, and addressing concerns of specific countries and regions.


Emerging Infectious Diseases | 2013

Rift Valley Fever and a New Paradigm of Research and Development for Zoonotic Disease Control

Osman Dar; Sabrina McIntyre; Sue Hogarth; David L. Heymann

To control this disease, funding and research should be prioritized on the basis of determined needs.


Lancet Infectious Diseases | 2014

Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spread.

Brian McCloskey; Osman Dar; Alimuddin Zumla; David L. Heymann

Summary Emerging infectious diseases are an important public health threat and infections with pandemic potential are a major global risk. Although much has been learned from previous events the evidence for mitigating actions is not definitive and pandemic preparedness remains a political and scientific challenge. A need exists to develop trust and effective meaningful collaboration between countries to help with rapid detection of potential pandemic infections and initiate public health actions. This collaboration should be within the framework of the International Health Regulations. Collaboration between countries should be encouraged in a way that acknowledges the benefits that derive from sharing biological material and establishing equitable collaborative research partnerships. The focus of pandemic preparedness should include upstream prevention through better collaboration between human and animal health sciences to enhance capacity to identify potential pathogens before they become serious human threats, and to prevent their emergence where possible. The one-health approach provides a means to develop this and could potentially enhance alignment of global health and trade priorities.


Tropical Medicine & International Health | 2011

Millennium development goals and the water target: details, definitions and debate

Osman Dar; Mishal S Khan

One of the primary targets of MDG 7, dealing with issues of environmental sustainability, is to halve by 2015 (from 1990 levels) the proportion of the population without sustainable access to safe drinking water and basic sanitation. It is undoubtedly difficult to summarise a complex target such as access to water or safety of water source in a single quantifiable indicator. However, in our opinion, the indicators used to estimate how much of the population has ‘access’ to ‘safe’ drinking water leave out some important elements that should be taken into account when determining whether the goals have been met. In addition, the authors propose a modification to Bradley’s classification of water‐related illness to include a category for waterborne diseases of a non‐infectious aetiology.


International Journal of Infectious Diseases | 2016

Communicable disease surveillance and control in the context of conflict and mass displacement in Syria

Sharif Ismail; Aula Abbara; Simon M Collin; Miriam Orcutt; Adam Coutts; Wasim Maziak; Zaher Sahloul; Osman Dar; Tumena Corrah; Fouad M. Fouad

OBJECTIVES To describe trends in major communicable diseases in Syria during the ongoing conflict, and the challenges to communicable disease surveillance and control in the context of dynamic, large-scale population displacement, unplanned mass gatherings, and disruption to critical infrastructure. METHODS A rapid review of the peer-reviewed and non-peer-reviewed literature from 2005 to 2015 was performed, augmented by secondary analysis of monitoring data from two disease early warning systems currently operational in Syria, focusing mainly on three diseases: tuberculosis (TB), measles, and polio. RESULTS Trend data show discrepancies in case report numbers between government and non-government controlled areas, especially for TB, but interpretation is hampered by uncertainties over sentinel surveillance coverage and base population numbers. Communicable disease control has been undermined by a combination of governance fragmentation, direct and indirect damage to facilities and systems, and health worker flight. CONCLUSIONS Five years into the crisis, some progress has been made in disease surveillance, but governance and coordination problems, variable immunization coverage, and the dynamic and indiscriminate nature of the conflict continue to pose a serious threat to population health in Syria and surrounding countries. The risk of major cross-border communicable disease outbreaks is high, and challenges for health in a post-conflict Syria are formidable.


BMJ | 2014

Prevention is better than cure for emerging infectious diseases

David L. Heymann; Osman Dar

Emerging infectious diseases have the potential to cause considerable morbidity, mortality, and economic damage. David Heymann and Osman Dar explain why we need to shift the emphasis from responding to emerging infections once they are detected to preventing them from occurring in the first place and describe one initiative that is working to achieve this


Lancet Infectious Diseases | 2016

Pathogens, prejudice, and politics: the role of the global health community in the European refugee crisis

Mishal S Khan; Anna Osei-Kofi; Abbas Omar; Hilary Kirkbride; Anthony Kessel; Aula Abbara; David L. Heymann; Alimuddin Zumla; Osman Dar

Summary Involuntary migration is a crucially important global challenge from an economic, social, and public health perspective. The number of displaced people reached an unprecedented level in 2015, at a total of 60 million worldwide, with more than 1 million crossing into Europe in the past year alone. Migrants and refugees are often perceived to carry a higher load of infectious diseases, despite no systematic association. We propose three important contributions that the global health community can make to help address infectious disease risks and global health inequalities worldwide, with a particular focus on the refugee crisis in Europe. First, policy decisions should be based on a sound evidence base regarding health risks and burdens to health systems, rather than prejudice or unfounded fears. Second, for incoming refugees, we must focus on building inclusive, cost-effective health services to promote collective health security. Finally, alongside protracted conflicts, widening of health and socioeconomic inequalities between high-income and lower-income countries should be acknowledged as major drivers for the global refugee crisis, and fully considered in planning long-term solutions.


Journal of Public Health | 2013

Mapping the Gypsy Traveller community in England: what we know about their health service provision and childhood immunization uptake

Osman Dar; Maya Gobin; Sue Hogarth; Chris Lane; Mary Ramsay

BACKGROUND A series of reports over the last two decades have concluded that the overall health status of UK Gypsy Traveller Community is very poor when compared with the general population and relatively poor in comparison with other disadvantaged groups. Despite a government commitment to reducing health inequalities, differences in health outcomes and in healthcare access and service provision have persisted. METHODS In order to understand immunization services for Gypsy Travellers, the Health Protection Agency conducted a survey and mapping exercise of Primary Care Trusts in England to ascertain what is known about local Gypsy Traveller populations, estimate immunizations rates and describe current services to increase immunization as well as to address wider health issues. RESULTS Despite improvements in the provision of specialist services for the Gypsy Traveller communities in England, there still remains a considerable number of areas where knowledge of population numbers is poor, service provision is not based on need and the uptake of immunization is low or not known. CONCLUSION There is an ongoing need to improve knowledge of population numbers and the provision of and access to services that are culturally sensitive and responsive to the needs of Gypsy Traveller communities. Whilst we have focused on describing immunization uptake, immunization services are only one component of a wider strategy for improving the health of Gypsy Travellers through effective health and social care interventions.

Collaboration


Dive into the Osman Dar's collaboration.

Top Co-Authors

Avatar

Alimuddin Zumla

University College London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Esam I. Azhar

King Abdulaziz University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Matthew Bates

University College London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Peter Mwaba

University College London

View shared research outputs
Top Co-Authors

Avatar

Giuseppe Ippolito

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge